40 results
8-K
EX-1.1
APTO
Aptose Biosciences Inc
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
are consummated or this Agreement is terminated, all costs and expenses incident to the public offering of the Securities and the performance … to the Underwriters; and (vi) all reasonable out-of-pocket costs and expenses incident to the offering and the performance of the obligations of the Representative
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
to protect against cyber-attacks.
Disruptions due to cyber security incidents could adversely affect our business. In particular, a cyber security incident
424B3
ay1f 8tkexpc
6 Jul 23
Prospectus supplement
4:01pm
S-1
yackr
16 Jun 23
IPO registration
6:42pm
8-K
EX-10.2
y4trk6a 12w48ons1e
26 May 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
0i7na
12 Dec 22
Entry into a Material Definitive Agreement
8:00am
8-K
EX-1.1
pkq10vid7pp ztpt
16 Jul 20
Aptose Announces Pricing of Public Offering of Common Shares
4:05pm
8-K
EX-10.1
rtj5706w7xwi
5 May 20
Aptose Reports Results for the First Quarter 2020
5:01pm
8-K
EX-1.1
cctb1xtrmc 2xv
17 Dec 19
Aptose Announces Pricing of Public Offering of Common Shares
2:27pm
8-K
EX-1.1
8rp dr11bsi8gm8kvxk
30 May 19
Aptose Announces Pricing of Public Offering of Common Shares
4:13pm
8-K
EX-10.1
l8k0hj7sinko736
24 May 19
Entry into a Material Definitive Agreement
5:20pm
424B5
o5jpac tb5
13 May 19
Prospectus supplement for primary offering
12:00am
10-Q
51n86m y386d
7 May 19
Quarterly report
4:47pm